Purdue University Northwest, USA
* Corresponding author

Article Main Content

The sequelae of long-term complications of COVID-19 have been reported in many studies. These complications are almost similar in both adults and children and were observed during infection with other coronaviruses like SARS-CoV and MERS-CoV. It is observed too that these complications develop in both previously symptomatic and asymptomatic individuals. The symptoms of long COVID start to manifest usually after 4-12 weeks of initial onset of SARS-CoV-2 infection. In the long run, COVID-19 affects various body parts in different ways. These majorly include respiratory, cardiovascular, hematological, inflammatory, immunological, and neurological disorders along with gastrointestinal, metabolic, renal, hepatic, and skin disorders. However, there is a lack of detailed summary of the clinical presentation and effects of long COVID in the literature. This review summarizes the current evidence of the long-term effects of COVID-19 in adults and children along with the presenting signs and symptoms in these patients. This finding highlights the need for future epidemiological studies to access the risk of long-term complications of COVID-19 in order to develop effective multi-disciplinary risk reduction and management strategies for long COVID in patients.

References

  1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. [Internet] 2022 [cited 2022 May 18] Available from: https://covid19.who.int/.
     Google Scholar
  2. World Health Organization. Update 54 – clinical long-term effects of COVID-19. [Internet] 2021 [cited 2022 May 18] Available from: https://www.who.int/publications/m/item/update-54-clinical-long-term-effects-of-covid-19.
     Google Scholar
  3. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. The BMJ. 2020; 370: 2019–2020.
    DOI  |   Google Scholar
  4. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021; 11(1): 1–12.
    DOI  |   Google Scholar
  5. World Health Organization. A clinical case definition of post covid-19 condition by a Delphi Consensus, 6 October 2021. [Internet] 2021 [cited 2022 May 16] Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.
     Google Scholar
  6. Carfì A, Bernabei R, Landi GF. Against COVID-19. Post-Acute Care Study Group: for the Gemelli Against CCOVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020.
    DOI  |   Google Scholar
  7. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020; 5(11): 1265–1273.
    DOI  |   Google Scholar
  8. Joshee S, Vatti N, Chang C. Long-Term Effects of COVID-19. Mayo Clinic Proceedings. Elsevier. Chicago. 2022.
    DOI  |   Google Scholar
  9. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021; 594(7682): 259-264.
    DOI  |   Google Scholar
  10. Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Annals of Internal Medicine. 2021; 174(4): 576–578.
    DOI  |   Google Scholar
  11. Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection A Systematic Review. JAMA Network Open. 2021; 4(10): 1–17.
    DOI  |   Google Scholar
  12. Centers for Disease Control and Prevention. (2022). Long COVID or Post-COVID conditions. Centers for Disease Control and Prevention. [Internet] 2022 [cited 2022 May 16] Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html Buonsenso D, Munblit D, De RC, Sinatti D, Ricchiuto A, Carfi A, et al. Preliminary evidence on long COVID in children. Acta Paediatrica. 2021; 110(7): 2208–2211.
    DOI  |   Google Scholar
  13. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single- centre longitudinal study. Clinical Microbiology and Infection Journal. 2021; 27(1): 89–95.
    DOI  |   Google Scholar
  14. Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Medical Hypotheses. 2021; 146: 110469.
    DOI  |   Google Scholar
  15. Rogers JP, Chesney E, Oliver D, Pollak TA, Mcguire P, Fusar-poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry. 2020; 7(7): 611–627.
    DOI  |   Google Scholar
  16. Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerging Microbes & Infections. 2020; 9(1): 2190–2199.
    DOI  |   Google Scholar
  17. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal. 2020; 55(6): 2001217.
    DOI  |   Google Scholar
  18. Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Research. 2020.
    DOI  |   Google Scholar
  19. Das KM, Lee EY, Singh R, Enani MA, Al DK, Van GK, et al. Follow‑up chest radiographic findings in patients with MERS‑CoV after recovery. The Indian Journal of Radiology & Imaging. 2021; 27(3): 342–349.
    DOI  |   Google Scholar
  20. Wang Y, Dong C, Yue H, Li C, Ren Q, Zhang X, et al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020; 296(2): E55–E64. https://doi.org/10.1148/radiol.2020200843.
    DOI  |   Google Scholar
  21. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID ‑ 19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020; 46(5): 846–848.
    DOI  |   Google Scholar
  22. Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Heart Rhythm. 2020; 17(9): 1472–1479.
    DOI  |   Google Scholar
  23. Peluso MJ, Deitchman AN, Torres L, Greenhouse B, Rutishauser RL, Henrich T., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19. Cell Reports. 2021; 36(6): 109518.
    DOI  |   Google Scholar
  24. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clinical Immunology (Orlando, Fla.). 2020; 215: 108427.
    DOI  |   Google Scholar
  25. Marzano AV, Genovese G, Fabbrocinic G, Pigatto P, Monfrecola G, Piraccini BM, et al. Varicella-like exanthem as a specific COVID-19 associated skin manifestation: Multicenter case series of 22 patients. Journal of the American Academy of Dermatology. 2020; 83(1): 280–285.
    DOI  |   Google Scholar
  26. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2020; 397(January): 19–21.
     Google Scholar